Dermipsor’s mission is to develop new therapeutic treatments for people suffering from a variety of skin diseases that severely impact their quality of life. The company has generated a pipeline of proprietary drugs that offer better efficacy and safety than existing products, and is focused of bringing them to the market as soon as possible.

Dermipsor focuses on the dermatology market, where there are major unmet medical needs for safe and efficacious drugs. Its novel synergistic technologies offer new solutions for patients suffering from psoriasis, atopic dermatitis and other skin conditions.